Risk factors for relapse of resectable pathologic N2 non small lung cancer and prediction model for time-to-progression
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference21 articles.
1. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group;Vansteenkiste;Ann Thorac Surg,1997
2. What to do with “surprise” N2? Intraoperative management of patients with non-small cell lung cancer;Detterbeck;J Thorac Oncol,2008
3. Prognosis of completely resected pN2 non-small cell lung carcinomas: what is the significant node that affects survival?;Okada;J Thorac Cardiovasc Surg,1999
4. Aggressive surgical intervention in N2 non-small cell cancer of the lung;Watanabe;Ann Thorac Surg,1991
5. The role of surgery in N2 lung cancer;Martini;Surg Clin North Am,1987
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of skip N2 lymph node metastasis for patients with the stage III-N2 lung adenocarcinoma: a propensity score matching analysis;BMC Pulmonary Medicine;2023-04-28
2. Postoperative long-term survival of non-small cell lung cancer patients with skip-N2 metastases;Surgical Oncology;2021-09
3. Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non–small-cell Lung Cancer: A Propensity Score Matching Analysis;Clinical Lung Cancer;2019-05
4. Food for thought: Autophagy researcher wins 2016 Nobel Prize in Physiology or Medicine;Biomedical Journal;2017-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3